The clinical trial data, including the SURMOUNT series showing average weight loss of 15-21% depending on dose, comes from these FDA-approved formulations
In conclusion, while the combination of semaglutide and the ketogenic diet holds considerable promise for enhancing health outcomes in individuals with obesity and type 2 diabetes, it is not a one-size-fits-all solution
Over a dozen lawsuits claim Ozempic and Wegovy caused patients to go blind The Independent is reporting that lawsuits claiming the popular weight-loss medication Ozempic is causing blindness are piling up, with more than a dozen legal filings pending across the country
Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease
Science 352 , 14361443 (2016)
There may also be potential beneficial effects of l-carnitine supplementation in regard to the central nervous system